These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Kuhn RJ; Gelrud A; Munck A; Caras S Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085 [TBL] [Abstract][Full Text] [Related]
4. Postgastrectomy pancreatic malabsorption: is there a case for intervention? Griffiths A; Taylor RH Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):219-21. PubMed ID: 10333191 [TBL] [Abstract][Full Text] [Related]
5. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities. Alkaade S; Vareedayah AA Am J Manag Care; 2017 Jul; 23(12 Suppl):S203-S209. PubMed ID: 28727474 [TBL] [Abstract][Full Text] [Related]
6. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency. Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255 [TBL] [Abstract][Full Text] [Related]
7. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447 [TBL] [Abstract][Full Text] [Related]
8. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes. Lewis DM; Shahid A J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705 [TBL] [Abstract][Full Text] [Related]
9. Less common etiologies of exocrine pancreatic insufficiency. Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency. Caras S; Boyd D; Zipfel L; Sander-Struckmeier S J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of pancreatic insufficiency in patients with gastrectomy due to cancer or gastric ulcers: a virtual roundtable expert discussion. Croagh D; Michalski CW; van Berge Henegouwen MI; Alfieri S Expert Rev Gastroenterol Hepatol; 2023 Dec; 17(12):1313-1319. PubMed ID: 38108090 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management. Dunleavy L; Al-Mukhtar A; Halliday V Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R; Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156 [TBL] [Abstract][Full Text] [Related]
14. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy. Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398 [TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Graff GR; McNamara J; Royall J; Caras S; Forssmann K Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244 [TBL] [Abstract][Full Text] [Related]
18. Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency. Klassen PN; Mazurak VC; Baracos V; Martin L; Ghosh S; Kasnik J; Sawyer MB Clin Nutr; 2024 Aug; 43(8):1900-1906. PubMed ID: 38991415 [TBL] [Abstract][Full Text] [Related]
19. Exocrine pancreatic insufficiency and fat malabsorption related to pancreatectomy and other gastrointestinal surgery: A narrative review. Morris-Stiff G Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S35-S45. PubMed ID: 38429966 [TBL] [Abstract][Full Text] [Related]